Monday Morning Movers (TEVA, QSFT, STZ)

Loading...
Loading...
Teva Pharmaceuticals TEVA
: Teva traded up about 6.5% early in the session on Monday. Teva's patent for its drug Copaxone was upheld by a U.S. District Court. Momenta Pharmaceuticals
MNTA
challenged Teva's patent for its Multiple Sclerosis drug. Dr. Jeremy Levin, Teva's President and Chief Executive Officer stated, “Teva is confident COPAXONE will remain a proprietary, global market leading product for the reduction of relapses in patients with RRMS over the product's lifecycle given the strength of its intellectual property rights.”
Quest Software QSFT:
On Monday, Quest Software announced it had received a proposal from a strategic bidder to acquire all of the outstanding shares of Quest common stock for $27.50 per share in cash. Reuters reported that the bidder is Dell
DELL
. Quest traded up about 5.5% early in the day on Monday.
Constellation Brands STZ:
Constellation Brands, a producer and marketer of alcohol in the United States, traded up about 10% early on Monday. Anheuser-Busch InBev
BUD
is in talks to take over Modelo, a Mexican brewer. Modelo brews Corona, and Constellations Brand is a distributer of Corona in the United States.
Posted In: Long IdeasNewsShort IdeasRumorsFDAM&AIntraday UpdateMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...